High sensitivity assay for detection BCR-ABL with T315I mutation in CML patients

被引：0
|
作者：
Chen, R. S. [1 ]
Bagaskoro, F. [1 ]
Handayani, D. A. [1 ]
机构：
[1] Prodia Clin Lab, Jakarta, Indonesia
来源：
CLINICA CHIMICA ACTA | 2019年 / 493卷
关键词：
D O I：
10.1016/j.cca.2019.03.1216
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
W297
引用
收藏
页码：S580 / S580
页数：1
相关论文
共 50 条
  • [1] Quantitative monitoring of T315I BCR-ABL mutation by the invader assay
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Najima, Yuho
    Kikuchi, Taku
    Nagata, Yasunobu
    Ueki, Toshimitsu
    Kobayashi, Takeshi
    Yamashita, Takuya
    Akiyama, Hideki
    Yamaguchi, Toshikazu
    Sakamaki, Hisashi
    BLOOD, 2007, 110 (11) : 207B - 207B
  • [2] Detection of BCR-ABL T315i Mutation in Imatinib Resistant Chronic Myeloid Leukemia Patients
    Mardziah, M.
    Salwati, S.
    Azlin, I
    Hafiza, A.
    Farisah, Noor A. R.
    Noraesah, M.
    Tumian, N. R.
    Wong, C. L.
    Azma, R. Z.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2019, 14 (01): : 145 - 156
  • [3] Quantitative monitoring of BCR-ABL mRNA harboring the T315I mutation in chronic myeloid leukemia (CML)
    Chomel, Jean-Claude
    Sorel, Nathalie
    Guilhot, Francois
    Turhan, Ali G.
    BLOOD, 2007, 110 (11) : 858A - 858A
  • [4] Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
    Masahide Yamamoto
    Kazuhiko Kakihana
    Kazuteru Ohashi
    Toshikazu Yamaguchi
    Kenichi Tadokoro
    Hideki Akiyama
    Hisashi Sakamaki
    International Journal of Hematology, 2009, 89 : 482 - 488
  • [5] Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment
    Oaxaca, Derrick M.
    Yang-Reid, Sun Ah
    Ross, Jeremy A.
    Rodriguez, Georgialina
    Staniswalis, Joan G.
    Kirken, Robert A.
    TUMOR BIOLOGY, 2016, 37 (09) : 12643 - 12654
  • [6] Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
    Yamamoto, Masahide
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Yamaguchi, Toshikazu
    Tadokoro, Kenichi
    Akiyama, Hideki
    Sakamaki, Hisashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (04) : 482 - 488
  • [7] Role of BCR in the resistance of BCR/ABL harboring the T315I mutation
    Rafiei, A.
    Metodieva, A. T.
    Ottmann, O. G.
    Serve, H.
    Ruthardt, M.
    Mian, A. A.
    ONKOLOGIE, 2011, 34 : 5 - 5
  • [8] THE TRANSPHOSPHORYLATION OF BCR IN THE RESISTANCE OF BCR/ABL HARBORING THE T315I MUTATION
    Ruthardt, M.
    Mian, A.
    Metodieva, A.
    Rafiei, A.
    Serve, H.
    Ottmann, O.
    Ruthardt, M.
    HAEMATOLOGICA, 2012, 97 : 2 - 2
  • [9] Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation
    Liang Jiang
    Yuting Wang
    Qian Lia
    Zhengchao Tu
    Sihua Zhu
    Sanfang Tu
    Zhang Zhang
    Ke Ding
    Xiaoyun Lu
    ActaPharmaceuticaSinicaB, 2021, 11 (05) : 1315 - 1328
  • [10] Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
    Lu, X. Y.
    Cai, Q.
    Ding, K.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (14) : 2146 - 2157
12345